PANDx is the leader in the precision pathogen detection field with tNGS and mNGS. We tested over 500,000 samples in 2024, and 60% growth is expected to be maintained annually. In collaboration with clinical laboratory experts and partners, we have published more than 30 SCI articles in the field of microbiology and infection in the last three years.